vigabatrin has been researched along with Innate Inflammatory Response in 1 studies
Excerpt | Relevance | Reference |
---|---|---|
" Furthermore, most preclinical antiepileptogenic studies lack information needed for translation, such as dose-blood level relationship, brain target engagement, and dose-response, and many use treatment parameters that cannot be applied clinically, for example, treatment initiation before or at the time of injury and dosing higher than tolerated human equivalent dosing." | 2.66 | Repurposed molecules for antiepileptogenesis: Missing an opportunity to prevent epilepsy? ( Bar-Klein, G; Friedman, A; Hameed, MQ; Jozwiak, S; Kaminski, RM; Klein, P; Klitgaard, H; Koepp, M; Löscher, W; Prince, DA; Rotenberg, A; Twyman, R; Vezzani, A; Wong, M, 2020) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Klein, P | 1 |
Friedman, A | 1 |
Hameed, MQ | 1 |
Kaminski, RM | 1 |
Bar-Klein, G | 1 |
Klitgaard, H | 1 |
Koepp, M | 1 |
Jozwiak, S | 1 |
Prince, DA | 1 |
Rotenberg, A | 1 |
Twyman, R | 1 |
Vezzani, A | 1 |
Wong, M | 1 |
Löscher, W | 1 |
1 review available for vigabatrin and Innate Inflammatory Response
Article | Year |
---|---|
Repurposed molecules for antiepileptogenesis: Missing an opportunity to prevent epilepsy?
Topics: Acetylcysteine; Animals; Anticonvulsants; Antioxidants; Atorvastatin; Brain Injuries, Traumatic; Cef | 2020 |